Extracellular matrix remodeling: Multiple paradigms in vascular disease

Circulation Research

Volumn 88, Issue 1, 2001, Pages 2-4

  Turley, E A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

CD44; Collagen gel contraction; Extracellular matrix; Marfan syndrome; Remodeling

Indexed keywords

EDITORIAL; EXTRACELLULAR MATRIX; HUMAN; MARFAN SYNDROME; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STENOSIS; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 0035910621     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.88.1.2     Document Type: Editorial

References (40)

1. The influence of the microenvironment on the malignant phenotype
2. The tenascin family of EMC glycoproteins: Structure, function and regulation during embryonic development and tissue remodeling
3. Serine protease inhibitors: Novel therapeutic targets for stroke?
4. Homocyst(e)ine and heart disease: Pathophysiology of extracellular matrix
5. Remodeling of the coronary artery after vascular injury
6. Elastase and the pathobiology of unexplained pulmonary hypertension
7. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome
8. Hyaluronan enhances contraction of collagen by smooth muscle cells and adventitial fibroblasts: Role of CD44 and implications for constrictive remodeling
9. The Marfan syndrome
10. Fibrillin-rich microfibrils of the extracellular matrix: Ultrastructure and assembly
11. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1
12. The synthetic metalloproteinase inhibitor batimastat suppresses injury-induced phosphorylation of MAP kinase ERK1/ERK2 and phenotypic modification of arterial smooth muscle cells in vitro
13. Size matters: The relationship between MMP-9 expression and aortic diameter
14. Restenosis: A challenge for pharmacology
15. The extracellular matrix in balloon arterial injury: A novel target for restenosis prevention
16. Wound healing: A paradigm for lumen narrowing after arterial reconstruction
17. The comparative pathobiology of atherosclerosis and restenosis
18. Mechanisms of restenosis after angioplasty and approach to therapy
19. Cardiovascular gene therapy
20. Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow: Potential mechanisms and clinical implications
21. Extracellular matrix and cardiovascular diseases
22. The cardiovascular manifestations of genetic disorders of collagen metabolism
23. Increased hyaluronan and hyaluronidase production and hyaluronan degradation injured aorta of insulin-resistant rats
24. Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries
25. The role of hyaluronan and its receptors in restenosis after balloon angioplasty: Development of a potential therapy
26. Cell-free synthesis of hyaluronic acid in Marfan syndrome
27. Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury
28. The extracellular matrix dynamically regulates smooth muscle cell responsiveness to PDGF
29. Hetertrimeric G proteins in heart disease
30. Protein tyrosine kinase inhibitors as novel therapeutic agents
31. Inflammatory mediators and stroke: New opportunities for novel therapeutics
32. Scarless wound healing in the mammalian fetus
33. Studies in fetal wound healing, IV: Hyaluronic acid-stimulating activity distinguishes fetal wound fluid from adult wound fluid
34. Using hyaluronic acid to create a fetal-like environment in vitro
35. Hyaluronic acid stimulates human fibroblast proliferation within a collagen matrix
36. Crosslinked CNBr-activated hyaluronan-collagen matrices: Effects on fibroblast contraction
37. Migration of bovine aortic smooth muscle cells after wounding injury: The role of hyaluronan and RHAMM
38. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells
39. CD44v(3.8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells
40. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion